These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 6697294)

  • 1. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms.
    Murphy WM; Soloway MS; Jukkola AF; Crabtree WN; Ford KS
    Cancer; 1984 Apr; 53(7):1555-65. PubMed ID: 6697294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micropapillary variant of transitional cell carcinoma of the urinary bladder: a report of three cases with cytologic diagnosis in urine specimens.
    Ylagan LR; Humphrey PA
    Acta Cytol; 2001; 45(4):599-604. PubMed ID: 11480725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine cytology in bladder tumors.
    Zein TA; Milad MF
    Int Surg; 1991; 76(1):52-4. PubMed ID: 2045253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of bladder washings and urine cytology in the diagnosis of bladder cancer and its correlation with selected biopsies of the bladder mucosa.
    Zein T; Wajsman Z; Englander LS; Gamarra M; Lopez C; Huben RP; Pontes JE
    J Urol; 1984 Oct; 132(4):670-1. PubMed ID: 6471209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A study of dysplasia associated with bladder cancer--histopathological findings of bladder giant sections and related urinary cytology].
    Sekine H
    Nihon Hinyokika Gakkai Zasshi; 1989 Apr; 80(4):545-54. PubMed ID: 2747096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status of urinary cytology in the evaluation of bladder neoplasms.
    Murphy WM
    Hum Pathol; 1990 Sep; 21(9):886-96. PubMed ID: 2203672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytology of grade 1 papillary transitional cell carcinoma. A comparison of cytologic, architectural and morphometric criteria in cystoscopically obtained urine.
    Renshaw AA; Nappi D; Weinberg DS
    Acta Cytol; 1996; 40(4):676-82. PubMed ID: 8693885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results.
    Curry JL; Wojcik EM
    Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis.
    Raab SS; Lenel JC; Cohen MB
    Cancer; 1994 Sep; 74(5):1621-6. PubMed ID: 8062194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value of voided urine and bladder barbotage cytology in detecting transitional cell carcinoma of the urinary tract.
    Konety BR; Metro MJ; Melham MF; Salup RR
    Urol Int; 1999; 62(1):26-30. PubMed ID: 10436427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
    Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ
    Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
    Whisnant RE; Bastacky SI; Ohori NP
    Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for urothelial malignancies by cytologic analysis and flow cytometry in a community urologic practice: a prospective study.
    Gourlay W; Chan V; Gilks CB
    Mod Pathol; 1995 May; 8(4):394-7. PubMed ID: 7567937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review.
    Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U
    Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine cytology findings in patients with biopsy-confirmed urothelial carcinoma in situ with plasmacytoid features.
    Nichols MM; Reynolds JP; McKenney JK; Nicolas MM; McIntire PJ; Policarpio-Nicolas MLC
    Cancer Cytopathol; 2021 Oct; 129(10):798-804. PubMed ID: 33900681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of "cannibalism" in urinary cytology of bladder cancer.
    Kojima S; Sekine H; Fukui I; Ohshima H
    Acta Cytol; 1998; 42(6):1365-9. PubMed ID: 9850644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary cytology for carcinoma in situ of the urinary bladder.
    Rosa B; Cazin M; Dalian G
    Acta Cytol; 1985; 29(2):117-24. PubMed ID: 3856981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytologic evaluation of low grade transitional cell carcinoma and instrument artifact in bladder washings.
    Chu YC; Han JY; Han HS; Kim JM; Suh JK
    Acta Cytol; 2002; 46(2):341-8. PubMed ID: 11917583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.